Coronavirus Vaccine: Moderna Secures Another $472 Million

Coronavirus Vaccine: Moderna Secures Another $472 Million

Moderna has been making lots of headlines when it revealed that we’re just one step away from having a vaccine. Tests have reportedly entered the final phase and this sparked massive enthusiasm around the world. 

On the other hand, it’s been recently revealed that Microsoft co-founder Bill Gates said recently that an effective coronavirus vaccine could require multiple doses

“None of the vaccines at this point appear like they’ll work with a single dose,” Gates told CBS News.

Also, we addressed the fact that there’s one new potential treatment for the novel coronavirus. More than that, it’s important to mention the fact that an Italian infectious disease expert believes that the virus is becoming less and less dangerous, and it could eventually disappear without a vaccine, on its own.

Moderna secures another $472 million for their vaccine efforts 

It’s been just reported by MarketWatch that the biotech company Moderna Inc. MRNA, -2.81% on Sunday announced, “the U.S. government has committed up to an additional $472 million to its efforts to develop a coronavirus vaccine. In a statement, the drugmaker said the funding would go to late-stage clinical development, including an expanded Phase 3 study of its vaccine candidate,” according to official notes. 

More than a single shot

It’s been also revealed that we might be needing more than just a single shot. 

There’s been a lot of research around the idea that the coronavirus antibodies are dissipating after a period of a few weeks or months. These findings are suggesting that our immunity to the virus might be pretty transient.

The efficacy of a vaccine lingers on its ability to prompt the body to generate antibodies that are protecting us from future infections.

Business Insider just noted the fact that the body could need two doses of a vaccine that should be a few weeks apart in order tor the vaccine to be effective. 

Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.